Deborah Birx Armata Pharmaceuticals, Inc. (ARMP) insider trading activity

ARMP Quotes by TradingView

Deborah Birx is Chief Executive Officer of Armata Pharmaceuticals, Inc.. Currently has a direct ownership of 217,377 shares of ARMP, which is worth approximately $552,137. The most recent transaction as insider was on Jul 10, 2025, when has been sold 13,637 shares (Common Stock) at a price of $2.27 per share, resulting in proceeds of $30,955. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 217K
5.9% 3M change
8.31% 12M change
Total Value Held $552,137

Deborah Birx Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 10 2025
SELL
Payment of exercise price or tax liability
$30,955 $2.27 p/Share
13,637 Reduced 5.9%
217,377 Common Stock
Mar 14 2025
SELL
Payment of exercise price or tax liability
$11,818 $1.95 p/Share
6,061 Reduced 2.56%
231,014 Common Stock
Jul 10 2024
SELL
Payment of exercise price or tax liability
$61,439 $2.68 p/Share
22,925 Reduced 8.82%
237,075 Common Stock
Mar 14 2024
BUY
Grant, award, or other acquisition
-
60,000 Added 18.75%
260,000 Common Stock
Dec 21 2023
BUY
Grant, award, or other acquisition
-
200,000 Added 50.0%
200,000 Common Stock

Also insider at

INVA
Innoviva, Inc. Healthcare
Director
DB

Deborah Birx

Chief Executive Officer
Burlingame, CA

Track Institutional and Insider Activities on ARMP

Follow Armata Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARMP shares.

Notify only if

Insider Trading

Get notified when an Armata Pharmaceuticals, Inc. insider buys or sells ARMP shares.

Notify only if

News

Receive news related to Armata Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARMP